Back to Journals » ClinicoEconomics and Outcomes Research » Volume 3

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Total article views   Abstract views HTML views PDF downloads Totals
14,739 Dovepress* 12,846 504+ 3,223 13,350
PubMed Central* 7 1,382 713 1,389
Totals 12,853 1,886 3,936 14,739
*Since 25 January 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar